Jump to ContentJump to Main Navigation
Show Summary Details

Hardt, Annika

Technikfolgenabschätzung des CRISPR/Cas-Systems

Über die Anwendung in der menschlichen Keimbahn

[A Technology Impact Assessment of the CRISPR/Cas System: On its Use in the Human Genome]

    49,95 € / $57.99 / £45.50*

    eBook (PDF)
    Publication Date:
    January 2019
    Copyright year:
    See all formats and pricing


    Aims and Scope

    Since the description of the CRISPR/Cas System as a potential “gene splicer” in 2012, the idea of precise alteration of the genome in human germ cells and embryos has seemed to come within reach. This book provides a profound risk-benefit presentation that considers both individual and societal aspects and offers a differentiated presentation of competing positions in the debate about this controversial intervention.


    24.0 x 17.0 cm
    x, 312 pages
    Type of Publication:
    Specialist Text
    Gene splicing; gene technology; germ cells; embryos; genome; bioethics

    MARC record

    MARC record for eBook

    request permissions

    More ...

    Comments (0)

    Please log in or register to comment.
    Log in